Who
Jesse Neri
SVP and CFO
Company insider
Files Form 4 as: SVP and CFO, Rockwell Medical.
In numbers
- Trades disclosed
- 18
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $4,966
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 16 Oct 2023
- Last trade
- 1 Jul 2026
- Last filed
- 6 Jul 2026
Companies traded
Activity over time
1 Mar 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 6 Jul 2026 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 14 Mar 2026filed 16 Mar 2026 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code F | $2,2002,444 at $0.90 | filing |
| 14 Mar 2026filed 16 Mar 2026 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code F | $2,2002,444 at $0.90 | filing |
| 2 Jan 2026filed 5 Jan 2026 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Sold | $740886 at $0.8355 | filing |
| 2 Jan 2026filed 5 Jan 2026 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Sold | $744886 at $0.84 | filing |
| 1 Oct 2025filed 1 Oct 2025 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Sold | $1,054886 at $1.19 | filing |
| 1 Jul 2025filed 3 Jul 2025 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Sold | $727886 at $0.82 | filing |
| 1 Jul 2025filed 2 Jul 2025 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Sold | $727886 at $0.82 | filing |
| 20 May 2025filed 17 Apr 2026 | RMTI Rockwell Medicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —97,500 at $0.00 | filing |
| 20 May 2025filed 17 Apr 2026 | RMTI Rockwell Medicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —97,500 at $0.00 | filing |
| 20 May 2025filed 21 May 2025 | RMTI Rockwell Medicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —195,000 at $0.00 | filing |
| 20 May 2025filed 21 May 2025 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —97,500 at $0.00 | filing |
| 1 Apr 2025filed 2 Apr 2025 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Sold | $975886 at $1.10 | filing |
| 14 Mar 2025filed 18 Mar 2025 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code F | $4,1552,444 at $1.70 | filing |
| 14 Mar 2024filed 15 Mar 2024 | RMTI Rockwell Medicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —47,190 at $0.00 | filing |
| 14 Mar 2024filed 15 Mar 2024 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —33,330 at $0.00 | filing |
| 16 Oct 2023filed 18 Oct 2023 | RMTI Rockwell Medicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
News
Rockwell Medical (NASDAQ:RMTI) Shares Cross Above Two Hundred Day Moving Average After Analyst DowngradeRMTI · tickerreport.com · 17 Oct 2026
0 headlines in the last 90 days name Jesse Neri; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.